Lawrence Steinman - Jun 17, 2025 Form 4/A - Amendment Insider Report for 180 Life Sciences Corp. (ATNF)

Role
Director
Signature
/s/ Lawrence Steinman
Stock symbol
ATNF
Transactions as of
Jun 17, 2025
Transactions value $
$0
Form type
4/A - Amendment
Date filed
6/30/2025, 05:34 PM
Date Of Original Report
Jun 20, 2025
Previous filing
Feb 21, 2025
Next filing
Jun 18, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
STEINMAN LAWRENCE Director 3000 EL CAMINO REAL, BLDG. 4,, SUITE 200, PALO ALTO /s/ Lawrence Steinman 2025-06-30 0001132679

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATNF Common Stock Award $0 +45K +66.57% $0.00 112K Jun 17, 2025 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATNF Non-Qualified Stock Option (right to buy) Award $0 +110K $0.00 110K Jun 17, 2025 Common Stock 110K $0.93 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock shares subject to time-based vesting, which vest at the rate of 1/2 of such shares on each of December 17, 2025 and June 17, 2026, subject to the recipient's continued service to the Issuer. Issued under the Issuer's 2022 Equity Compensation Plan (the "Equity Plan").
F2 Issued to the Reporting Person in consideration for services rendered and agreed to be rendered to the Issuer as a member of the Board of Directors of the Issuer.
F3 The options vest 1/2 on each of December 17, 2025 and June 17, 2026, subject to the recipient's continued service to the Issuer. Issued under the Issuer's 2025 Option Incentive Plan. The 2025 Option Incentive Plan is subject to stockholder approval and (i) no options can be exercised prior to obtaining stockholder approval for such plan, and (ii) the outstanding options will be cancelled, if stockholder approval is not obtained.

Remarks:

This Form 4/A is being filed to reflect the fact that the number of shares awarded to the Reporting Person was retroactively adjusted by the Board of Directors and Compensation Committee of the Company on June 28, 2025, so that there was sufficient room for such award, and other awards made on the same date, under the Equity Plan.